Pediatric phase I trial design using maximum target inhibition as the primary endpoint.
Meany H; Balis FM; Aikin A; Whitcomb P; Murphy RF; Steinberg SM; Widemann BC; Fox E; Journal Of The National Cancer Institute, 2010, vol. 102, issue 12, p 909, ISSN 14602105. ISBN 14602105.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef